| Product Name | MF | CAS | Details |
|---|
| 4-(But-3-yn-1-yloxy)benzaldehyde | C11H10O2 | 1016536-59-6 | Details |
| 1-(6-Hydroxy-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one | C11H13NO2 | 42443-04-9 | Details |
| PPM1L antibody | Details |
| 2-Cyclohexaneamido-4,5-dimethoxybenzoic acid | C16H21NO5 | 294892-11-8 | Details |
| 3,3-Dimethyl-1,2,3,4-tetrahydroquinoline | C11H15N | 112565-69-2 | Details |
| (5,5-Dimethyl-4,5,6,7-tetrahydro-1,2-benzoxazol-3-yl)methanol | C10H15NO2 | 1504762-46-2 | Details |
| Furo[3,2-c]pyridin-2-ylmethanamine dihydrochloride | C8H9ClN2O | 153863-96-8 | Details |
| 3-(2,2-Difluoroethoxy)benzoic acid | C9H8F2O3 | 812700-19-9 | Details |
| 1-(1,4-Diazepan-1-yl)ethanone | C7H14N2O | 61903-11-5 | Details |
| 2-Propanoyl-3-picoline | C9H11NO | 917872-34-5 | Details |
| N6-Benzoyl-3'-deoxyadenosine | C17H17N5O4 | 76902-49-3 | Details |
| HIV1 Vif Antibody | Details |
| Ac-CDGPTEIYKLTRKEAQE-OH | Details |
| Methyl 2-azaspiro[3.3]heptane-6-carboxylate hydrochloride | C8H14ClNO2 | 2361634-43-5 | Details |
| (5-Fluoro-2-hydroxyphenyl)(1-oxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid | C16H12FNO4 | 2236558-68-0 | Details |
| Gypenoside XLIX | C52H86O21 | 94987-08-3 | Details |
| N-Acetyl-5-bromo-3-indoxyl-2,3,4-tri-O-acetyl-beta-D-glucuronic acid methyl ester | C23H24BrNO11 | Details |
| 5-(Furan-2-yl)-4-(2-methylpropyl)-4H-1,2,4-triazole-3-thiol | C10H13N3OS | 438235-35-9 | Details |
| Lamivudine | C8H11N3O3S | 134678-17-4 | Details |
| ACPP Blocking Peptide | Details |
| Chlamydia Pneumoniae IgM Positive Human Plasma | Details |
| tert-Butyl (phenylmethylene)carbamate | C12H15NO2 | 150884-50-7 | Details |
| 4-Bromo-3-iodonitrobenzene | C6H3BrINO2 | 63037-63-8 | Details |
| tert-Butyl (2R,3S)-3-hydroxy-2-methylpyrrolidine-1-carboxylate | C10H19NO3 | 817554-87-3 | Details |
| 1-(Pyrimidin-5-yl)-1H-pyrazol-3-amine | C7H7N5 | 1367992-26-4 | Details |
| UBLCP1 antibody | Details |
| 7-Chloro-4-fluoro-2,3-dihydro-1H-inden-1-one | C9H6ClFO | 881190-28-9 | Details |
| N-(Prop-2-en-1-yl)cyclooctanamine hydrochloride | C11H22ClN | 1803603-52-2 | Details |
| Caloxanthone C | C23H22O5 | 155566-36-2 | Details |
| 3-(3,4-Dimethoxyphenyl)propanal | C11H14O3 | 61871-67-8 | Details |
| 1,2,3,4-Tetrahydroquinoline-3-sulfonamide | C9H12N2O2S | 1909337-28-5 | Details |
| L-Buthionine-(S,R)-sulfoximine | C8H18N2O3S | 83730-53-4 | Details |
| Borrelia burgdorferi IgM Positive Human Plasma | Details |
| Febuxostat - Bio-X ? | C16H16N2O3S | 144060-53-7 | Details |
| 2-(Azepan-1-yl)-5-(trifluoromethyl)aniline | C13H17F3N2 | 858126-26-8 | Details |
| CHCHD3 protein (His tag) | Details |
| Angelol G | C20H24O7 | 83199-38-6 | Details |
| 3-Amino-3-benzyl-1-(3,4-dichlorophenyl)thiourea | C14H13Cl2N3S | 723332-86-3 | Details |
| Sanfetrinem cilexetil | C23H33NO8 | 141646-08-4 | Details |
| 1-N,1-N,3-N-Trimethylbenzene-1,3-diamine | C9H14N2 | 84995-19-7 | Details |
| Carbetocin (acetate) | C47H73N11O14S | 1631754-28-3 | Details |
| 7-Cyano-7-deaza-2’-deoxyguanosine | C12H13N5O4 | 199859-58-0 | Details |
| 1-Chloro-N-(1,2,3,4-tetrahydronaphthalen-1-yl)methanesulfonamide | C11H14ClNO2S | 1340105-87-4 | Details |
| 5-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | C7H7NO3 | 66909-27-1 | Details |
| BPH715 | C17H31NO7P2 | 1059677-23-4 | Details |
| 6-Methoxy-2,3-dihydropyridazin-3-one | C5H6N2O2 | 1703-10-2 | Details |
| 1-(2,3-Dichlorophenyl)-N-methylmethanamine hydrochloride | C8H10Cl3N | 39959-78-9 | Details |
| 5-Chlorouracil | C4H3ClN2O2 | 1820-81-1 | Details |
| 3-(Benzyloxy)-2-methylpropan-1-amine hydrochloride | C11H18ClNO | 1197466-21-9 | Details |
| Dihydrozeatin | C10H15N5O | 23599-75-9 | Details |
| 18:1 Pi(4)P | C45H84O16P2 | 1803104-55-3 | Details |
| PYR-5120 | C12H17NO3 | 59435-12-0 | Details |
| H-KIVL-NH2 | Details |
| 6-Chloro-N2-cyclopropyl-N4-(propan-2-yl)-1,3,5-triazine-2,4-diamine | C9H14ClN5 | 22936-86-3 | Details |
| 2-(3-Bromophenyl)-2-(methylamino)acetamide | C9H11BrN2O | 1218221-61-4 | Details |
| Doublecortin antibody (Ser376) | Details |
| anti-Mouse IgG1 Fc Antibody (Goat) - Affinity Purified | Details |
| 2-(2,5-Difluorophenyl)-4-nitrobenzoic acid | C13H7F2NO4 | 1261942-55-5 | Details |
| 2-Amino-3-chloro-9,10-dihydroanthracene-9,10-dione | C14H8ClNO2 | 84-46-8 | Details |
| {[4-(Benzyloxy)-3-methoxyphenyl]methyl}(methyl)amine hydrochloride | 88741-50-8 | Details |
| 4,7-Dihydro-5H-thieno[2,3-c]pyran-7-methanamine hydrochloride | C8H12ClNOS | 1310421-50-1 | Details |
| 2-Amino-1-(5-hydroxypyridin-3-yl)ethan-1-one dihydrochloride | C7H9ClN2O2 | 2126163-20-8 | Details |
| N,N-Dimethyl-2,3,4,5-tetrahydro-1H-2-benzazepin-8-amine | C12H18N2 | 2248332-74-1 | Details |
| N-(Piperidin-4-yl)cyclohexanecarboxamide hydrochloride | C12H23ClN2O | 41823-26-1 | Details |
| H-DPPSEPSPLEAEFQR-OH | Details |
| Rabbit anti Chicken IgG/Y (H + L) | Details |
| 2-(Bromomethyl)-1,1-difluorocyclopentane | C6H9BrF2 | 1871494-10-8 | Details |
| 5,5-Diethoxy-5,6,7,8-tetrahydroquinolin-6-amine | 2375259-18-8 | Details |
| TAF2 antibody | Details |
| 5-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-4H,5H,6H,7H-furo[3,2-c]pyridine-4-carboxylic acid | C23H19NO5 | 2137513-13-2 | Details |
| 4-Fluoro-2-[1-(methoxymethoxy)ethyl]benzaldehyde | C11H13FO3 | 2044871-85-2 | Details |
| H-dPEG?4-Glu[dPEG?4(Cyclo(Arg-Gly-Asp-d-Phe-Lys))]2 | Details |
| N-(2-Methoxyphenyl)-2-methylpyridin-3-amine | C13H14N2O | 1909318-78-0 | Details |
| Methyl 2-(2-acetamido-1,3-thiazol-4-yl)acetate | C8H10N2O3S | 126781-71-3 | Details |
| 2-Chloro-3-methylpentan-1-ol | C6H13ClO | 1378687-06-9 | Details |
| 1-Benzyloxy-2-bromo-4-t-butylbenzene | C17H19BrO | 52458-11-4 | Details |
| 3,4-Dimethyl-2,6-dinitroaniline | C8H9N3O4 | 40318-31-8 | Details |
| Vaniliprole | C20H10Cl2F6N4O2S | 145767-97-1 | Details |
| (3-Amino-1,1,1-trifluoropropan-2-yl)(benzyl)propylamine | C13H19F3N2 | 1158017-93-6 | Details |
| 1-(5-Bromopyrimidin-2-yl)cyclobutan-1-amine hydrochloride | 2135587-14-1 | Details |
| 1-[2-(2,2,2-Trifluoroethoxy)ethyl]-1H-pyrazol-3-amine | C7H10F3N3O | 1249244-67-4 | Details |
| MAPK1/3 antibody | Details |
| 3-Chloro-6-(oxetan-3-yloxy)pyridazine | C7H7ClN2O2 | 1601827-79-5 | Details |
| 3-Methyl-1,2,3,4-tetrahydrophthalazin-1-one hydrochloride | 2095410-07-2 | Details |
| Methyl 5,6-dichloro-2-methylpyridine-3-carboxylate | C8H7Cl2NO2 | 1039037-66-5 | Details |
| NFAT inhibitor, Cell Permeable | C147H259N67O36S | 592517-80-1 | Details |
| 2-(2-Pyridylamino)-4-methyl-1,3-thiazole-5-carboxylic acid | C10H9N3O2S | 1216058-53-5 | Details |
| 6-[1-(Hydroxyimino)ethyl]-1,3-dioxaindan-5-amine | C9H10N2O3 | 157593-00-5 | Details |
| AKAP10 antibody | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-2-methyl-4-phenylbutanoic acid | C16H23NO4 | 1411655-63-4 | Details |
| Ethyl 4-(pyridin-3-yl)-1,3-thiazole-2-carboxylate hydrobromide | C11H11BrN2O2S | 1421602-11-0 | Details |
| 3-[5-(1-Methyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-3-yl]morpholine | C10H13N5O2 | 1461705-69-0 | Details |
| 1-(4-((6,7-dimethoxy(3,4-dihydroisoquinolyl))methyl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea | C26H24F3N3O4 | 1023493-40-4 | Details |
| 4-(Methylthio)benzhydrazide | C8H10N2OS | 81104-42-9 | Details |
| 8-Fluoro-2-methylquinoline-3-carboxylic acid hydrochloride | C11H9ClFNO2 | 1803599-81-6 | Details |
| 1H-Pyrrole-2,3-dicarboxylic acid | C6H5NO4 | 1125-32-2 | Details |
| H-ISFNFFVTAPK^-OH | Details |
| MIP3 alpha protein (Mouse) | Details |
| Methyl(4H-1,2,4-triazol-3-ylmethyl)amine hydrochloride | C4H9ClN4 | 1803562-00-6 | Details |
| Estrone D5 b-D-glucuronide | Details |
| Product Total： Product Page： | ||||
| 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 | ||||